메뉴 건너뛰기




Volumn 95, Issue 33, 2016, Pages

Erratum: The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (Medicine and Science in Sports and Exercise 95:33 (e4541) DOI: 10.1097/MD.0000000000004541);The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy

Author keywords

alogliptin; metformin; obesity; oxidative related substances; pulmonary function; type 2 diabetes mellitus

Indexed keywords

ALOGLIPTIN; CARBON MONOXIDE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; PIPERIDINE DERIVATIVE; URACIL;

EID: 84983490181     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.md.0000505546.85718.ea     Document Type: Erratum
Times cited : (16)

References (41)
  • 1
    • 84875641584 scopus 로고    scopus 로고
    • Type 2 diabetes in East Asians: Similarities and differences with populations in Europe and the United States
    • Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013;1281:64-91.
    • (2013) Ann N y Acad Sci , vol.1281 , pp. 64-91
    • Ma, R.C.1    Chan, J.C.2
  • 2
    • 84943174795 scopus 로고    scopus 로고
    • Assessment of blood glucose regulation and safety of resistant starch formula-based diet in healthy normal and subjects with type 2 diabetes
    • Lin CH, Chang DM, Wu DJ, et al. Assessment of blood glucose regulation and safety of resistant starch formula-based diet in healthy normal and subjects with type 2 diabetes. Medicine 2015;94:e1332.
    • (2015) Medicine , vol.94 , pp. e1332
    • Lin, C.H.1    Chang, D.M.2    Wu, D.J.3
  • 3
    • 84864388040 scopus 로고    scopus 로고
    • Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications
    • Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 2012;9:6-22.
    • (2012) Rev Diabet Stud , vol.9 , pp. 6-22
    • Murea, M.1    Ma, L.2    Freedman, B.I.3
  • 4
    • 84924328397 scopus 로고    scopus 로고
    • Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
    • Yamagishi S, Fukami K, Matsui T. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol 2015;14:2.
    • (2015) Cardiovasc Diabetol , vol.14 , pp. 2
    • Yamagishi, S.1    Fukami, K.2    Matsui, T.3
  • 5
    • 80053515769 scopus 로고    scopus 로고
    • The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus and macro vascular complications: Avenues for a mechanistic based therapeutic approach
    • Folli F, C orradi D, Fanti P, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus and macro vascular complications: avenues for a mechanistic based therapeutic approach. Curr Diabetes Rev 2011;7:313-24.
    • (2011) Curr Diabetes Rev , vol.7 , pp. 313-324
    • Folli, F.1    Orradi, D.C.2    Fanti, P.3
  • 6
    • 84876273640 scopus 로고    scopus 로고
    • Hyperglycemia induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases
    • Fiorentino TV, Prioletta A, Zuo P, et al. Hyperglycemia induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharma Des 2013;19:5695-703.
    • (2013) Curr Pharma des , vol.19 , pp. 5695-5703
    • Fiorentino, T.V.1    Prioletta, A.2    Zuo, P.3
  • 8
    • 84866645242 scopus 로고    scopus 로고
    • Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: Role of dipeptidyl peptidase-IV inhibition
    • Rizzo MR, Barbieri M, Marfella R, et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-82.
    • (2012) Diabetes Care , vol.35 , pp. 2076-2082
    • Rizzo, M.R.1    Barbieri, M.2    Marfella, R.3
  • 9
    • 84883888603 scopus 로고    scopus 로고
    • Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus
    • Anandhalakshmi S, Manikandan S, Ganeshkumar P, et al. Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus. J Clin Diagn Res 2013;7:1874-7.
    • (2013) J Clin Diagn Res , vol.7 , pp. 1874-1877
    • Anandhalakshmi, S.1    Manikandan, S.2    Ganeshkumar, P.3
  • 10
    • 84859929091 scopus 로고    scopus 로고
    • Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men
    • Kwon CH, Rhee EJ, Song JK, et al. Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men. Cardiovasc Diabetol 2012;11:38.
    • (2012) Cardiovasc Diabetol , vol.11 , pp. 38
    • Kwon, C.H.1    Rhee, E.J.2    Song, J.K.3
  • 11
    • 84874931230 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho dependent mechanism
    • Wang DJ, Luo P, Wang Y, et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho dependent mechanism. Diabetes 2013;62:1697-708.
    • (2013) Diabetes , vol.62 , pp. 1697-1708
    • Wang, D.J.1    Luo, P.2    Wang, Y.3
  • 12
    • 77949472676 scopus 로고    scopus 로고
    • Incretin-based therapies: New treatments for type 2 diabetes in the new millennium
    • Khoo J, Rayner CK, Jones KL, et al. Incretin-based therapies: new treatments for type 2 diabetes in the new millennium. Ther Clin Risk Manag 2009;5:683-98.
    • (2009) Ther Clin Risk Manag , vol.5 , pp. 683-698
    • Khoo, J.1    Rayner, C.K.2    Jones, K.L.3
  • 13
    • 79961222810 scopus 로고    scopus 로고
    • Pharmacology of dipeptidyl peptidase-4 inhibitors: Similarities and differences
    • Baetta R, Corsini A. Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. Drugs 2011;71:1441-67.
    • (2011) Drugs , vol.71 , pp. 1441-1467
    • Baetta, R.1    Corsini, A.2
  • 14
    • 58149171060 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: A randomized, double-blind, placebocontrolled study
    • Defronzo RA, Fleck PR, Wilson CA, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebocontrolled study. Diabetes Care 2008;31:2315-7.
    • (2008) Diabetes Care , vol.31 , pp. 2315-2317
    • Defronzo, R.A.1    Fleck, P.R.2    Wilson, C.A.3
  • 15
    • 84898798397 scopus 로고    scopus 로고
    • Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    • Lukashevich V, Del Prato S, Araga M, et al. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea. Diabetes Obes Metab 2014;16:403-9.
    • (2014) Diabetes Obes Metab , vol.16 , pp. 403-409
    • Lukashevich, V.1    Del Prato, S.2    Araga, M.3
  • 16
    • 79959964310 scopus 로고    scopus 로고
    • Guideline: Type 2 diabetes mellitus therapy: Metformin, a critical perspective
    • Pinto D, Heleno B, Gallego R, et al. Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective. Acta Med Port 2011;24:331-8.
    • (2011) Acta Med Port , vol.24 , pp. 331-338
    • Pinto, D.1    Heleno, B.2    Gallego, R.3
  • 17
    • 78651338445 scopus 로고    scopus 로고
    • Standards of medical care in diabetes 2007
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care 2011;34(Suppl. 1):S11-61.
    • (2011) Diabetes Care , vol.34 , pp. S11-61
  • 18
    • 33745780301 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006;49:1711-21.
    • (2006) Diabetologia , vol.49 , pp. 1711-1721
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 19
    • 58149335320 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
    • Pratley RE, Kipnes MS, Fleck PR, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy. Diabetes Obes Metab 2009;11:167-76.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 167-176
    • Pratley, R.E.1    Kipnes, M.S.2    Fleck, P.R.3
  • 20
    • 57649225147 scopus 로고    scopus 로고
    • Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double-blind, placebo-controlled study
    • Nauck MA, Ellis GC, Fleck PR, et al. Alogliptin Study 2008 Group. Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study. Int J Clin Pract 2009;63:46-55.
    • (2009) Int J Clin Pract , vol.63 , pp. 46-55
    • Nauck, M.A.1    Ellis, G.C.2    Fleck, P.R.3
  • 21
    • 77953724336 scopus 로고    scopus 로고
    • Role of the glucagon-like peptide-1 receptor in the control of energy balance
    • Hayes MR, Jonghe BC, Kanoski SE. Role of the glucagon-like peptide-1 receptor in the control of energy balance. Physiol Behav 2010; 100:503-10.
    • (2010) Physiol Behav , vol.100 , pp. 503-510
    • Hayes, M.R.1    Jonghe, B.C.2    Kanoski, S.E.3
  • 22
    • 84881230708 scopus 로고    scopus 로고
    • Reactive aldehydes-second messengers of free radicals in diabetes mellitus
    • Jaganjac M, Tirosh O, Cohen G, et al. Reactive aldehydes-second messengers of free radicals in diabetes mellitus. Free Radic Res 2013;47:39-48.
    • (2013) Free Radic Res , vol.47 , pp. 39-48
    • Jaganjac, M.1    Tirosh, O.2    Cohen, G.3
  • 23
    • 84870242289 scopus 로고    scopus 로고
    • Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous root
    • Saddala RR, Thopireddy L, Ganapathi N, et al. Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous root. Exp Toxicol Pathol 2013;65:15-9.
    • (2013) Exp Toxicol Pathol , vol.65 , pp. 15-19
    • Saddala, R.R.1    Thopireddy, L.2    Ganapathi, N.3
  • 24
    • 84870571889 scopus 로고    scopus 로고
    • Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes
    • Tsai CJ, Hsieh CJ, Tung SC, et al. Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes. Diabetes Res Clin Prac 2012;98:257-63.
    • (2012) Diabetes Res Clin Prac , vol.98 , pp. 257-263
    • Tsai, C.J.1    Hsieh, C.J.2    Tung, S.C.3
  • 25
    • 84884915819 scopus 로고    scopus 로고
    • Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC
    • Patel H, Chen J, Das KC, et al. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Dialectol 2013;12:142-6.
    • (2013) Cardiovasc Dialectol , vol.12 , pp. 142-146
    • Patel, H.1    Chen, J.2    Das, K.C.3
  • 27
    • 34250710080 scopus 로고    scopus 로고
    • Lung function changes related to diabetes mellitus
    • Hsia CC, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther 2007;9(Suppl 1):S73-82.
    • (2007) Diabetes Technol Ther , vol.9 , pp. S73-82
    • Hsia, C.C.1    Raskin, P.2
  • 28
    • 0033366583 scopus 로고    scopus 로고
    • Body mass index, diabetes, and C-reactive protein among U S adults
    • Ford E. Body mass index, diabetes, and C-reactive protein among U. S. adults. Diabetes Care 1999;22:1971-7.
    • (1999) Diabetes Care , vol.22 , pp. 1971-1977
    • Ford, E.1
  • 29
    • 0345102427 scopus 로고    scopus 로고
    • Increased levels of C-reactive protein in noncontrolled type 2 diabetic subjects
    • Rodriguez M, Guerrero R. Increased levels of C-reactive protein in noncontrolled type 2 diabetic subjects. J Diabetes Complications 1999; 13:211-5.
    • (1999) J Diabetes Complications , vol.13 , pp. 211-215
    • Rodriguez, M.1    Guerrero, R.2
  • 30
    • 0036172495 scopus 로고    scopus 로고
    • Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus
    • Tan K, ChowW, Tam S, et al. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002;87:563-8.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 563-568
    • Tan, K.1    Chow, W.2    Tam, S.3
  • 31
    • 0013088326 scopus 로고    scopus 로고
    • The role of inflammation and anti-inflammatorymedication in asthma
    • Barnes PJ. The role of inflammation and anti-inflammatorymedication in asthma. Respir Med 2002;96(Suppl A):S9-15.
    • (2002) Respir Med , vol.96 , pp. S9-15
    • Barnes, P.J.1
  • 32
    • 0023089068 scopus 로고
    • Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus
    • Sandler M, Bunn A, Stewart R. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987;135:223-8.
    • (1987) Am Rev Respir Dis , vol.135 , pp. 223-228
    • Sandler, M.1    Bunn, A.2    Stewart, R.3
  • 33
    • 0031446351 scopus 로고    scopus 로고
    • Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus
    • Niranjan V, McBrayer DG, Ramirez LC, et al. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J 1997;103:504-13.
    • (1997) Am J , vol.103 , pp. 504-513
    • Niranjan, V.1    McBrayer, D.G.2    Ramirez, L.C.3
  • 34
    • 0034308197 scopus 로고    scopus 로고
    • Reduced pulmonary function and its associations in type 2 diabetes: The Fremantle Diabetes Study
    • Davis TM, Knuiman M, Kendall P, et al. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000;50:153-9.
    • (2000) Diabetes Res Clin Pract , vol.50 , pp. 153-159
    • Davis, T.M.1    Knuiman, M.2    Kendall, P.3
  • 35
    • 0029905056 scopus 로고    scopus 로고
    • NIDDM, impaired glucose tolerance, and pulmonary function in older adults
    • The Rancho Bernardo Study
    • Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996;1441-4.
    • (1996) Diabetes Care , pp. 1441-1444
    • Barrett-Connor, E.1    Frette, C.2
  • 36
    • 0024533304 scopus 로고
    • Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study
    • Lange P, Groth S, Kastrup J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989;2:14-9.
    • (1989) Eur Respir J , vol.2 , pp. 14-19
    • Lange, P.1    Groth, S.2    Kastrup, J.3
  • 37
    • 34547863123 scopus 로고    scopus 로고
    • Sitagliptin Study 035 Group Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
    • Hermansen K, Kipnes M, Luo E, et al. Sitagliptin Study 035 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes Obes Metab 2007;9:733-45.
    • (2007) Diabetes Obes Metab , vol.9 , pp. 733-745
    • Hermansen, K.1    Kipnes, M.2    Luo, E.3
  • 38
    • 0025220777 scopus 로고
    • Diabetes mellitus and ventilatory capacity: A five year follow-up study
    • Lange P, Groth S, Mortensen J, et al. Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 1990;3:288-92.
    • (1990) Eur Respir J , vol.3 , pp. 288-292
    • Lange, P.1    Groth, S.2    Mortensen, J.3
  • 39
    • 0036900816 scopus 로고    scopus 로고
    • Copenhagen City Heart Study: Longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults
    • Lange P, Parner J, Schnohr P, et al. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002;20:1406-12.
    • (2002) Eur Respir J , vol.20 , pp. 1406-1412
    • Lange, P.1    Parner, J.2    Schnohr, P.3
  • 40
    • 0035097211 scopus 로고    scopus 로고
    • Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese non-diabetic subjects
    • Mannucci E, Ognibene A, Cremasco F, et al. Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese non-diabetic subjects. Diabetes Care 2001;24:489-94.
    • (2001) Diabetes Care , vol.24 , pp. 489-494
    • Mannucci, E.1    Ognibene, A.2    Cremasco, F.3
  • 41
    • 84969878808 scopus 로고    scopus 로고
    • Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: A nationwide, retrospective, Taiwanese-registry, cohort study
    • Lee AL, Chen BC, Mou CH, et al. Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwanese-registry, cohort study. Medicine 2016;95:2356-62.
    • (2016) Medicine , vol.95 , pp. 2356-2362
    • Lee, A.L.1    Chen, B.C.2    Mou, C.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.